Profil bibliographique

María José Villanueva Silva

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

12Publications signalées

96Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Lung Cancer Research StudiesLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)

Rocio Garcia-Carbonero, Marta Benavent, P. Jimenez-Fonseca, Alonso-Gordoa Teresa et autres

3 citationsJournal of Clinical Oncology

Accès ouvert 2022 articleOpenAlex

An analysis of prognostic factors in a cohort of low-grade gliomas and degree of consistency between RTOG and EORTC scores

Isaura Fernández Pérez, Diana Valverde, Concepción Fiaño Valverde, Jenifer Brea Iglesias et autres

4 citationsScientific Reports

2022 articleOpenAlex

Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer

Isaura Fernández Pérez, Lidia Vázquez Tuñas, Diego Pereiro Corbacho, C. Garcia Benito et autres

0 citationsClinical Breast Cancer

2021 conference-abstractOpenAlex

Results of phase II randomized study of intermittent versus continuous schedule of vemurafenib plus cobimetinib in BRAF-mutated advanced melanoma.

María González‐Cao, Clara Mayo de las Casas, Juana Oramás, Miguel‐Ángel Berciano‐Guerrero et autres

0 citationsJournal of Clinical Oncology

2021 conference-abstractOpenAlex

A phase II/III randomized double-blind study of octreotide acetate LAR with axitinib versus octreotide acetate LAR with placebo in patients with advanced G1-G2 NETs of non-pancreatic origin (AXINET trial-GETNE-1107).

Rocio García‐Carbonero, Marta Benavent, Paula Jiménez Fonseca, Daniel Castellano et autres

38 citationsJournal of Clinical Oncology

2019 conference-abstractOpenAlex

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy.

Noemí Álvarez, Marinha Costa Rivas, Sara Agraso Busto, Diego Pereiro Corbacho et autres

1 citationJournal of Clinical Oncology

Accès ouvert 2017 articleOpenAlex

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill, Michelino De Laurentiis et autres

47 citationsEuropean Journal of Cancer

2015 conference-abstractOpenAlex

Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cáncer (NS-NSCLC). A Galician Lung Cancer Group Study.

Ma Carmen Areses Manrique, Natalia Fernández Núñez, Marta Covela Rúa, Ana Herrero et autres

1 citationJournal of Clinical Oncology

2012 conference-abstractOpenAlex

Study of the usefulness of angiotensin type 1 receptor (AGTR1) as a possible response predictor in patients with metastatic breast cancer (mBC) subjected to chemotherapy and treatment with bevacizumab (AVALUZ Study).

Juan de la Haba-Rodríguez, Javier Salvador Bofill, Manuel Codés, Eva Ciruelos et autres

1 citationJournal of Clinical Oncology

2012 conference-abstractOpenAlex

AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: OS analysis.

J. Salvador, Eva Ciruelos, Manuel Codés, A. Jaén et autres

1 citationJournal of Clinical Oncology

2012 conference-abstractOpenAlex

Erlotinib as frontline treatment for elderly patients (p) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): GGCP044/09 study.

José Luis Fírvida Pérez, Sergio Vázquez Estévez, J. Casal Rubio, Miguel Alonso Bermejo et autres

0 citationsJournal of Clinical Oncology

2012 conference-abstractOpenAlex

GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC).

Sergio Vázquez Estévez, María José Villanueva Silva, José Luis Fírvida Pérez, Martín Lázaro Quintela et autres

0 citationsJournal of Clinical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.